Express News | Actuate Therapeutics Announces Closing of Initial Public Offering

Reuters16:05 ET

Express News | Actuate Therapeutics Shares Opened For Trade At $9.88/Share; IPO Priced At $8/Share On 2.8M Shares

BenzingaAug 13 10:54 ET

Express News | Trading Halt: Halt Status Updated at 10:35:00 AM ET: Quotation Resumption: IPO Security - Released for Quotation

BenzingaAug 13 10:35 ET

Actuate Therapeutics Prices IPO

MT NewswiresAug 13 04:23 ET

Reported Earlier, Actuate Therapeutics Prices $22.4M Initial Public Offering Of 2.8M Common Shares At $8/Share

BenzingaAug 13 03:52 ET

Actuate Therapeutics Is Biopharmaceutical Company Focused on Developing Therapies Difficult to Treat Cancers >ACTU

Dow JonesAug 12 21:13 ET